These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 2564629)

  • 21. Comparisons of the combined contributions of agonist binding frequency and intrinsic efficiency to receptor-mediated activation of adenylate cyclase.
    Stickle D; Barber R
    Mol Pharmacol; 1991 Aug; 40(2):276-88. PubMed ID: 1678853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. beta(1) and beta(2)-adrenergic receptor subtype effects in German shepherd dogs with inherited lethal ventricular arrhythmias.
    Sosunov EA; Gainullin RZ; Moise NS; Steinberg SF; Danilo P; Rosen MR
    Cardiovasc Res; 2000 Nov; 48(2):211-9. PubMed ID: 11054468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of cyclopentyladenosine on isoproterenol response in adult and senescent cardiac tissue from Fischer 344 rats.
    Kapicka CL; Montamat SC; Mudumbi RV; Jacks SM; Olson RD; Vestal RE
    J Pharmacol Exp Ther; 2000 May; 293(2):599-606. PubMed ID: 10773034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of L-type Ca current by denopamine, a nonparenteral partial beta 1 stimulant, in rabbit ventricular cells.
    Habuchi Y; Yamamoto T; Nishio M; Tanaka H; Morikawa J; Yoshimura M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):437-43. PubMed ID: 8897446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-related changes in beta-adrenergic neuroeffector systems in the human heart.
    White M; Roden R; Minobe W; Khan MF; Larrabee P; Wollmering M; Port JD; Anderson F; Campbell D; Feldman AM
    Circulation; 1994 Sep; 90(3):1225-38. PubMed ID: 8087932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the mechanism of action of the beta-1 partial agonist denopamine in regulation of myocardial contractility: effects on myocardial alpha adrenoceptors and intracellular Ca++ transients.
    Kohi M; Norota I; Takanashi M; Endoh M
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1292-300. PubMed ID: 8099618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing.
    Marzo KP; Frey MJ; Wilson JR; Liang BT; Manning DR; Lanoce V; Molinoff PB
    Circ Res; 1991 Dec; 69(6):1546-56. PubMed ID: 1659503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-adrenergic receptor number and adenylate cyclase function in denervated transplanted and cardiomyopathic human hearts.
    Denniss AR; Marsh JD; Quigg RJ; Gordon JB; Colucci WS
    Circulation; 1989 May; 79(5):1028-34. PubMed ID: 2540921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced effects of dopexamine on force of contraction in the failing human heart despite preserved beta 2-adrenoceptor subpopulation.
    Böhm M; Pieske B; Schnabel P; Schwinger R; Kemkes B; Klövekorn WP; Erdmann E
    J Cardiovasc Pharmacol; 1989 Oct; 14(4):549-59. PubMed ID: 2478768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac beta-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Evidence for catecholamine-mediated myocardial damage.
    White M; Wiechmann RJ; Roden RL; Hagan MB; Wollmering MM; Port JD; Hammond E; Abraham WT; Wolfel EE; Lindenfeld J
    Circulation; 1995 Oct; 92(8):2183-9. PubMed ID: 7554200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of beta-adrenergic blockade on papillary muscle function and the beta-adrenergic receptor system in noninfarcted myocardium in compensated ischemic left ventricular dysfunction.
    Warner AL; Bellah KL; Raya TE; Roeske WR; Goldman S
    Circulation; 1992 Nov; 86(5):1584-95. PubMed ID: 1330362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.
    Bristow MR; Ginsburg R; Minobe W; Cubicciotti RS; Sageman WS; Lurie K; Billingham ME; Harrison DC; Stinson EB
    N Engl J Med; 1982 Jul; 307(4):205-11. PubMed ID: 6283349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice.
    Collins S; Daniel KW; Rohlfs EM; Ramkumar V; Taylor IL; Gettys TW
    Mol Endocrinol; 1994 Apr; 8(4):518-27. PubMed ID: 7914350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Adenylate cyclase response to beta-adrenergic agonists in heart and brown adipose tissue].
    Garruti G; De Pergola G; Cignarelli M; Stock M; Giorgino R
    Minerva Endocrinol; 1990; 15(2):125-9. PubMed ID: 1983028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agonist-promoted high affinity state of the beta-adrenergic receptor in human neutrophils: modulation by corticosteroids.
    Davies AO; Lefkowitz RJ
    J Clin Endocrinol Metab; 1981 Oct; 53(4):703-8. PubMed ID: 6116722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-1-adrenoceptor agonists with low adenylate cyclase activation--theoretical and clinical implications.
    Chemnitius JM; Bing RJ
    Can J Cardiol; 1985; 1(3):186-90. PubMed ID: 2864992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta adrenoceptor interaction of full and partial agonists in the cat heart and soleus muscle.
    Hedberg A; Mattsson H
    J Pharmacol Exp Ther; 1981 Dec; 219(3):798-808. PubMed ID: 6117657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The human heart beta-adrenergic receptors. II. Coupling of beta 2-adrenergic receptors with the adenylate cyclase system.
    Waelbroeck M; Taton G; Delhaye M; Chatelain P; Camus JC; Pochet R; Leclerc JL; De Smet JM; Robberecht P; Christophe J
    Mol Pharmacol; 1983 Sep; 24(2):174-82. PubMed ID: 6136901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homologous vs. heterologous desensitization of the adenylate cyclase system in heart cells.
    Reithmann C; Werdan K
    Eur J Pharmacol; 1988 Sep; 154(1):99-104. PubMed ID: 2846330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart.
    Port JD; Gilbert EM; Larrabee P; Mealey P; Volkman K; Ginsburg R; Hershberger RE; Murray J; Bristow MR
    Circulation; 1990 Mar; 81(3):929-38. PubMed ID: 1968367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.